Skip to Content

Weekly Drug News Round Up - August 19, 2015

FDA Approves Sprout’s Addyi For Low Libido in Women

Addyi is contraindicated in liver disease, with use of alcohol, and with many prescription drugs Read More...

Addyi (flibanserin) by Sprout Pharmaceuticals was FDA-approved on Tuesday for the treatment of acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. Flibanserin is the first approved medication for HSDD, and is classified as a multifunctional serotonin agonist antagonist (MSAA). While the drug showed modest benefit in clinical trials, it’s side effects, including fainting with alcohol use, prompted many labeling restrictions: a Boxed Warning, a REMS plan, required certification for providers and pharmacies, and a Patient-Provider Agreement Form. Addyi is given daily as a 100 milligram (mg) tablet at bedtime. The most common side effects with Addyi are dizziness, sleepiness, nausea, fatigue, insomnia and dry mouth.

Raptor Pharmaceutical Receives FDA Approval of Expanded Label for Procysbi

Cystinosis is a rare genetic condition that affects an estimated 500 patients in the U.S and roughly 3,000 patients worldwide Read More...

Procysbi (cysteamine bitartrate) delayed-release capsules use has been expanded to treat children 2 to 6 years of age with nephropathic cystinosis. Procysbi is now approved for the treatment of nephropathic cystinosis in adult and in pediatric patients 2 years of age and older. Fatal if not treated in early childhood, cystinosis causes a protein building block called cystine to build up in all cells, tissues, and organs in the body. Cystinosis can causes kidney failure, slow body growth, and weak bones. The most commonly reported side effects are vomiting, nausea, abdominal pain, breath odor, diarrhea, skin odor, fatigue, rash, and headache.

Insulin Pumps vs. Injection: Which May Lower Risk of Early Death in Type 1 Diabetes?

Fewer than 50% of Americans with type 1 diabetes use an insulin pump, often due to lack of insurance coverage Read More...

A new 7-year study from Sweden, published in BMJ, shows that patients with type 1 diabetes who used an insulin pump instead of daily injections almost halved their risk of dying prematurely from heart disease or stroke. Insulin pumps deliver insulin through a tiny tube that's inserted under the skin but are not fully automated. The user still must program the pump to deliver the insulin, but this can be taught. Researchers say more study is need to determine if the lower risk of death is due to more steady blood glucose levels, better care due to education, or even some combination of other factors.

Avastin Not Linked to Higher Risk of Blindness: Study

Avastin costs $50 per injection, while Lucentis can cost as much as $2,000 per treatment Read More...

Avastin (bevacizumab) is used to treat wet age-related macular degeneration, a progressive disease of the eye that can cause vision loss. Analysis of a national claims data set shows that Avastin does not lead to a higher risk of an eye infection called endophthalmitis compared to those patients treated with Lucentis (ranibizumab). Researchers looked at more than 296,000 injections of Avastin and more than 87,000 injections of Lucentis. They found the rates of the serious eye infection were 0.017 percent for Avastin and 0.025 percent for Lucentis.

Itching to Know What to Do About Resistant Head Lice?

Head lice itch and are bothersome, but they do not transmit disease Read More...

Back-to-school can sometimes mean an infestation of those pesky head lice that can run rampant throughout an elementary school. In fact, 6 to 12 million U.S. children are infested with head lice every year. To make matters worse, a new report lists at least 25 states that have lice populations that don't respond to common over-the-counter (OTC) treatments, such as permethrin, due to overuse. Researchers found 100 percent resistance among 104 lice populations out of 109 that they tested. Prescription medications for lice that don't contain permethrin, like ivermectin (Stromectol), malathion (Ovide), or lindane shampoo (Kwell) remain effective against lice.